Biotech Rumor Mill Hopping After Hostile Bid for OSI Pharmaceuticals (OSIP)
Tweet Send to a Friend
The biotech rumor mill is in high-gear today after Japanese drugmaker Astellas launched a $52 per share hostile ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE